Otsuka Pharmaceutical Co., Ltd invites applications for the position of scientist to lead the global development of new CNS drugs. The successful applicant will lead a team of passionate professionals who strive to advance science, technology, and medicine by developing products designed to help people live better lives.
The successful applicant will start employment as a permanent employee at Tokushima Prefecture in Japan. However, he or she will be required to work at Otsuka facilities worldwide including USA, EU, Canada, China, and so on.
The starting date is as soon as practicable in 2011.
Qualifications
- PhD degree with two to five years combined post-doctoral and industrial experience, preferably in the pharmaceutical industry or biotechnology sector.
- Life scientist with expertise in neuroscience, or a medicinal and organic chemist.
- Disease area: Schizophrenia, Bipolar, Major depressive disorder, Alzheimer’s disease, Parkinson’s disease, and Epilepsy.
- Should display the attributes of a true leader and innovator.
- Fluent English speaker in order to have excellent global communication.
- No Japanese language skill is required. Otsuka is committed to ensuring the successful applicant’s smooth transition to life in Tokushima. This includes Japanese language classes.
Applicants should include a curriculum vitae written in English with a recent photograph, a list of publications, and a statement explaining former research/ work experience. Please keep application material to no more than five pages.
Applications should be sent to:
Human resources department,
Otsuka Pharmaceutical Co., Ltd.
463-10 Kagasuno, Kawauchi-cho
Tokushima 771-0192, Japan
Or Email: recruitRD@otsuka.jp (The entire application should be converted to PDF)
Review of applications will begin on December 20, 2010.
However, the search for candidates will remain open until the position is filled.
Salary: Annual stipend will be from $70,000, higher for experienced senior researchers.
Benefit Package: Housing allowance, health Insurance, commuting allowance, and corporate pension.
